m+Medelevator.RU
← Поиск публикаций
International journal of fertility & sterility · 2024

Prevalence and Risk Factors of Prenatal and Postnatal Depressive Symptoms in Babol Pregnancy Mental Health Registry: A Cross-Sectional Study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Barat Shahnaz, Shahrokhi Shirin, Mirtabar Seyyedeh Mahboubeh, Kheirkhah Farzan, Basirat Zahra, Shirafkan Hoda, Hamidia Angela, Hosseini Davood, Pahlavan Zeynab, Esmaeilzadeh Sedigheh, Buzari Zinatosadat, Zeynalzadeh Mahtab, Yazdani Charati Shahla, Ghanbarpour Azita, Shafizadeh Fatemeh, Adnani Mahsima, Amirkhanloo Fatemeh, Mollaalipour Maedeh, Chale Kani Atiyeh, Amiri Mania, Khazaei Razieh, Mehdinia Seyedeh Shabnam, Basirat Fatemeh, Hamzehpour Romina, Khademi Asieh, Azizi Alireza, Nasiri-Amiri Fatemeh, Fateri Nooshin, Zarinkamar Banafshe, Aligoltabar Sajedeh, Faramarzi Mahbobeh

Аннотация

BACKGROUND: Prenatal and postnatal depression (PND) is associated with adverse outcomes for mother, fetus, and child. The aim of study was to examine the prevalence and risk factors of prenatal and postnatal depressive symptoms.

MATERIALS AND METHODS: This was a cross-sectional and hospital-based survey of 2305 pregnant women and post-partum women (18-48 years) that was registered in the Babol Pregnancy Mental Health Registry (BPMHR) database from June 2020 to March 2021. Two questionnaires, including demographics and depression, were analyzed in this study. Also, the Edinburg Postnatal Depression Scale (EPDS) was used to assess the depressive symptoms. Independent t test and the analysis of variance were used to compare the means. Multiple logistic regressions were used to determine risk factors for depressive symptoms.

RESULTS: According to the EPDS scale, the prevalence of depressive symptoms was 19.8% in the pregnant woman group in comparison with the postpartum period (11.6%). Risk factors for antenatal depressive symptoms were parity (women with parity ≥ 4 vs. 1 parity, ß=1.808, P=0.020), two groups of gestational age (gestational age ≤12 weeks vs. 28 weeks, ß=1.562 P=0.030) as well as (gestational age 21-27 weeks vs. 28 weeks (ß=1.586, P=0.033), and high-risk pregnancy (high-risk vs. low-risk pregnancy, ß=1.457, P=0.003). For postnatal depressive symptoms, none of the factors were a significant risk.

CONCLUSION: Prenatal and postnatal depressive symptoms should be screened, particularly for women in the first and second trimesters, with high parity, and those with a high-risk pregnancy, as recommended by the present study.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты